Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease

Author： Prakash A.   Markham A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.3, 1999-03, pp. : 383-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Prolonged-Release Mesalazine: A Review of its Therapeutic Potential in Ulcerative Colitis and Crohn's Disease

By Clemett D.   Markham A.  

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 929-956

Adis International

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis

By McCormack Paul L.   Robinson Dean M.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2635-2642

Adis International

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Åke Nilsson

By Nilsson Åke  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2643-2644

Adis International

Access to resources Recommend Favorite

MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis

By Yang Lily P.H.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite